![5-Bromo-4-N-[2-(1H-imidazol-5-yl)ethyl]-2-N-[3-(morpholin-4-ylmethyl)phenyl]pyrimidine-2,4-diamine in PDB entry 7p1l, assembly 2, side view.](https://www.ebi.ac.uk/pdbe/static/entry/7p1l_entity_2_side_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>7p1l</span> contains 1 copy of <span class='highlight'>5-Bromo-4-N-[2-(1H-imidazol-5-yl)ethyl]-2-N-[3-(morpholin-4-ylmethyl)phenyl]pyrimidine-2,4-diamine</span>. Side view.")
![5-Bromo-4-N-[2-(1H-imidazol-5-yl)ethyl]-2-N-[3-(morpholin-4-ylmethyl)phenyl]pyrimidine-2,4-diamine in PDB entry 7p1l, assembly 2, top view.](https://www.ebi.ac.uk/pdbe/static/entry/7p1l_entity_2_top_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>7p1l</span> contains 1 copy of <span class='highlight'>5-Bromo-4-N-[2-(1H-imidazol-5-yl)ethyl]-2-N-[3-(morpholin-4-ylmethyl)phenyl]pyrimidine-2,4-diamine</span>. Top view.")
Environment details NEW
V5E 401 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.